|
T42.2X5A |
Adverse effect of succinimides and oxazolidinediones, initial encounter |
| Billable Code | is a billable ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. |
| GEMS |
| ICD-10-CM T42.2X5A converts approximately to:ICD-9-CM |
| 2015 ICD-9-CM 995.29 Unspecified adverse effect of other drug, medicinal and biological substance |
| GEMS |
| ICD-10-CM T42.2X5A converts approximately to:ICD-9-CM |
| 2015 ICD-9-CM E936.2 Succinimides causing adverse effects in therapeutic use |
| GEMS |
| ICD-10-CM T42.2X5A converts approximately to:ICD-9-CM |
| 2015 ICD-9-CM 995.29 Unspecified adverse effect of other drug, medicinal and biological substance |
| GEMS |
| ICD-10-CM T42.2X5A converts approximately to:ICD-9-CM |
| 2015 ICD-9-CM E936.0 Oxazolidine derivatives causing adverse effects in therapeutic use |
| ICD-10-CM T42.2X5Ais grouped within Diagnostic Related Group(s) (MS-DRG v30.0) |
| 793 FULL TERM NEONATE WITH MAJOR PROBLEMS
|
| 917 POISONING AND TOXIC EFFECTS OF DRUGS WITH MCC
|
| 918 POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MCC
|
| Alternate Description |
| Poisoning by succinimides and oxazolidinediones NOS |
